AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
PDS Biotechnology Corporation Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG004NCDKL7
1.11▼ 0.05 (-4.31%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.16
Day's Range
1.06 – 1.13
52-Week Range
0.20 – 1.79
Volume
2.6M
Avg Volume
32.0M
Share Statistics
Shares Outstanding
Employees
21
Exchange
XNAS
Listed
2015-10-01
Share count as of August 6, 2026

PDS Biotechnology Corporation Common Stock (PDSB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about PDS Biotechnology Corporation Common Stock (PDSB)
What is PDS Biotechnology Corporation Common Stock's Market Cap?
PDS Biotechnology Corporation Common Stock's Market Cap is $62.1M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PDSBAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development expenses
General and administrative expenses
Total operating expenses
Loss from operations
Interest income (expenses), net
Interest income
Interest expense
Interest income (expenses), net
Loss before income taxes
Benefit from income taxes
Net loss
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)